In this study, the ORRs in gastric cancer patients with HER2 IHC 2+/FISH−, IHC 2+/FISH+, and IHC 3+ statuses were 35.7% (5/14), 20% (2/10), and 13.6% (3/22), respectively. Here, ERBB2 is linked to gastric cancer.